Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Research site

CHU de Rouen - Hôpital Charles Nicolle

France 37 boulevard Gambetta, 76000 Rouen, France

  • 2 trials recruiting
  • Critical illness · Gastrooesophageal cancer · Gastric cancer
  • Adults and children

About Specializations

CHU de Rouen - Hôpital Charles Nicolle in Rouen, France specialises in clinical trials of conditions such as Critical illness, Gastrooesophageal cancer, Gastric cancer, Oesophageal carcinoma, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, with a particular focus on non-small cell lung cancer (NSCLC). The institution is dedicated to improving outcomes for patients with completely resected primary stage IB, II, and IIIA NSCLC through innovative therapeutic approaches.

  • Adjuvant Therapy
  • Immunotherapy
  • Disease-Free Survival

By exploring the efficacy of adjuvant therapy with novel agents like MEDI4736, the center aims to enhance disease-free survival rates in patients with specific genetic profiles, such as those with PD-L1 expression and EGFR-ALK- status.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
37 boulevard Gambetta76000 RouenFrance
Open in maps ↗
Recruiting now
2 trials
Conditions studied
10

More sites in RouenFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

Critical illness

Recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Epoetin Alfa
  • Sponsor:University College Dublin

Gastrooesophageal cancer+3

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Unicancer

Pancreatic neuroendocrine tumour

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Institut Gustave Roussy

Factor VIII deficiency

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Efanesoctocog Alfa
  • Sponsor:Swedish Orphan Biovitrum AB (publ)

Colon cancer

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Capecitabine
  • Sponsor:Fondation Franc.Cancerologie Digestive

Prostate cancer

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Leuprorelin Acetate
  • Sponsor:Unicancer

Non-small cell lung cancer

Not recruiting
Registered drug
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.